Publications by authors named "Deidra Smith"

Claim this Profile
I
Impact of age, obesity, and renal impairment on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.
Kelly J Gaffney, Jonathan K Bakos, Arash Velayati, James A Davis, Aswani Thurlapati, Deidra Smith

J Oncol Pharm Pract· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma.
James A Davis, Aswani Thurlapati, Erin Weeda, Kelly J Gaffney, Deidra Smith

Ann Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma.
James A Davis, Katelynn Granger, Alex Sakowski, Sara Goodwin, Amanda Herbst, Deidra Smith

Expert Rev Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Cytogenetic Abnormalities, Induction and Maintenance Regimens on Outcomes After High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma: A Decade-Long Real-World Experience.
Aswani Thurlapati, William Wesson, James A Davis, Kelly J Gaffney, Erin Weeda, Deidra Smith

J Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients.
Aswani Thurlapati, Mary McGann, James A Davis, Katelynn Granger, Kiera Roubal, Deidra Smith

J Med Virol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem Cell Mobilization for Multiple Myeloma Patients Receiving Daratumumab-Based Induction Therapy: A Real- World Experience.
Aswani Thurlapati, Kiera Roubal, James A Davis, Syed Z Shah, Deidra Smith

Transplant Cell Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ toxicities associated with chimeric antigen receptor T-cell therapy.
Mary McGann, Kelly J Gaffney, James A Davis, Deidra Smith, Hamza Hashmi

Leuk Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fever Characteristics and Impact on Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy.
James A Davis, Kelly J Gaffney, Mary McGann, Deidra Smith, Kathy Edwards

Clin Lymphoma Myeloma Leuk· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies.
James A Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J Gaffney

Blood· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant.
Abigail Shockley, James A Davis, Kelly J Gaffney, Deidra Smith, Erin Weeda

J Oncol Pharm Pract· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience and Optimization of Outpatient Chimeric Antigen Receptor T Cell Therapy.
Mary McGann, James A Davis, Kelly J Gaffney, Deidra Smith, Kathy Edwards

Transplant Cell Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis